Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 11 results:
[ Author] Title Type Year Filters: Author is Imprialos, Konstantinos P [Clear All Filters]
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?.
J Hypertens. 33(11), 2185-97.
(2015). The potential role of statins in treating liver disease..
Expert Rev Gastroenterol Hepatol. 12(4), 331-339.
(2018). The effect of SGLT2 inhibitors on cardiovascular events and renal function..
Expert Rev Clin Pharmacol. 10(11), 1251-1261.
(2017). Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 104-113.
(2018). Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?.
J Neurol Neurosurg Psychiatry. 88(3), 249-253.
(2017). Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes..
N Engl J Med. 377(25), 2502.
(2017). Current challenges in antihypertensive treatment in the elderly..
Pol Arch Med Wewn. 126(7-8), 540-51.
(2016). Antihypertensive drug treatment: the real-life challenge..
J Clin Hypertens (Greenwich). 20(1), 115-117.
(2018). Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?.
J Clin Hypertens (Greenwich). 18(8), 828.
(2016). Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs..
Cardiovasc Hematol Disord Drug Targets. 18(2), 83-85.
(2018). Liraglutide and Renal Outcomes in Type 2 Diabetes..
N Engl J Med. 377(22), 2196.
(2017).